Title : Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.

Pub. Date : 2007 Nov

PMID : 17427962






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway. Dinoprostone vascular endothelial growth factor A Homo sapiens
2 Prostaglandin E2 (PGE2) has been shown to induce expression of vascular endothelial growth factor (VEGF) and other signaling molecules in several cancers. Dinoprostone vascular endothelial growth factor A Homo sapiens
3 Prostaglandin E2 (PGE2) has been shown to induce expression of vascular endothelial growth factor (VEGF) and other signaling molecules in several cancers. Dinoprostone vascular endothelial growth factor A Homo sapiens
4 Prostaglandin E2 (PGE2) has been shown to induce expression of vascular endothelial growth factor (VEGF) and other signaling molecules in several cancers. Dinoprostone vascular endothelial growth factor A Homo sapiens
5 Prostaglandin E2 (PGE2) has been shown to induce expression of vascular endothelial growth factor (VEGF) and other signaling molecules in several cancers. Dinoprostone vascular endothelial growth factor A Homo sapiens
6 Treatment of prostate cancer cells with PGE2 (1 nM-10 microM) increased both VEGF secretion and cyclic adenosine monophosphate (cAMP) production. Dinoprostone vascular endothelial growth factor A Homo sapiens
7 We further demonstrated that the adenylate cyclase activator forskolin and the cAMP anologue 8-bromo-cAMP mimicked the effects of PGE2 on VEGF secretion in PC-3 cells. Dinoprostone vascular endothelial growth factor A Homo sapiens
8 We conclude that PGE2-induced VEGF secretion in prostate cancer cells is mediated through EP2-, and possibly EP4-, dependent cAMP signaling pathways. Dinoprostone vascular endothelial growth factor A Homo sapiens